The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Digital inhalers may help predict the occurrence of acute exacerbations of chronic obstructive pulmonary disease (COPD) for ...

Patients with chronic respiratory failure who meet usage criteria will have more access to respiratory assist devices.

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...

Antibiotic demand for pneumonia and COPD in the top 20 countries showed high global consumption. Researchers conducted a ...

Bronchiectasis causes your airways, called bronchi, to become damaged and widened over time. When you have bronchiectasis, ...

Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...

Between 14 days and 1 day out from an acute exacerbation of COPD, a digital inhaler measured significant drops in inhalation ...

Breathing should be effortless . But for millions, conditions like asthma and COPD (Chronic Obstructive Pulmonary Disease) ...

Theravance Biopharma’s partner Viatris has received China's National Medical Products Administration (NMPA) approval for ...

In February 2025 Harbour BioMed announced that the IND application for HBM9378 (SKB378), a TSLP-targeting monoclonal antibody ...

Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to ...